Soleno Therapeutics, Inc. (SLNO)
May 18, 2026 - SLNO was delisted (reason: acquired by NBIX)
53.01
0.00 (0.00%)
Inactive · Last trade price on May 15, 2026

Soleno Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Soleno Therapeutics stock had an average target of $53.

Price Target: $53 (-0.02%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$53$53$53$53
Change-0.02%-0.02%-0.02%-0.02%

Analyst Ratings

The average analyst rating for Soleno Therapeutics stock from 7 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
476.88M
from 190.41M
Increased by 150.46%
Revenue Next Year
717.10M
from 476.88M
Increased by 50.37%
EPS This Year
4.03
from 0.39
Increased by 932.64%
EPS Next Year
6.41
from 4.03
Increased by 59.18%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
----190.41M476.88M717.10M
Revenue Growth
-----150.46%50.37%
EPS
-5.81-2.87-2.36-4.380.394.036.41
EPS Growth
-----932.64%59.18%
Forward PE
-----13.168.27
No. Analysts
-----1412

Revenue Forecast

Revenue202620272028
High544.7M866.3M
Avg476.9M717.1M
Low425.0M528.6M

Revenue Growth

Revenue Growth202620272028
High
186.1%
81.6%
Avg
150.5%
50.4%
Low
123.2%
10.8%

EPS Forecast

EPS202620272028
High5.8310.42
Avg4.036.41
Low2.643.54

EPS Growth

EPS Growth202620272028
High
1,394.2%
158.6%
Avg
932.6%
59.2%
Low
575.9%
-12.2%